BIOTHERYX Trademark

Trademark Overview

On Monday, August 23, 2021, a trademark application was filed for BIOTHERYX with the United States Patent and Trademark Office. The USPTO has given the BIOTHERYX trademark a serial number of 90897381. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, February 14, 2024. This trademark is owned by BioTheryX, Inc.. The BIOTHERYX trademark is filed in the Pharmaceutical Products category with the following description:

Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, pharmaceutical preparations for restoring protein levels to treat diseases related to aberrant protein expression; none of the foregoing being pharmaceutical preparations for the treatment of anthrax, anthrax vaccines, or vaccines
biotheryx

General Information

Serial Number90897381
Word MarkBIOTHERYX
Filing DateMonday, August 23, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, February 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesMedical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, pharmaceutical preparations for restoring protein levels to treat diseases related to aberrant protein expression; none of the foregoing being pharmaceutical preparations for the treatment of anthrax, anthrax vaccines, or vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioTheryX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBioTheryX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, February 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 26, 2021NEW APPLICATION ENTERED
Friday, October 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 7, 2022LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, May 25, 2022ASSIGNED TO EXAMINER
Wednesday, May 25, 2022LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, May 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 27, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, October 21, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, October 26, 2022ASSIGNED TO PETITION STAFF
Wednesday, October 26, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, January 6, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2023SOU EXTENSION 1 FILED
Tuesday, August 15, 2023SOU EXTENSION 1 GRANTED
Thursday, August 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 14, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 14, 2024SOU EXTENSION 2 FILED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

biotheryx pharmaceutical preparations medical vaccines anthrax protein none expression treatment aberrant